Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation Thirty probands were enrolled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback